Stearoyl-CoA desaturase inhibition blocks formation of hepatitis C virus-induced specialized membranes

Hepatitis C virus (HCV) replication is dependent on the formation of specialized membrane structures; however, the host factor requirements for the formation of these HCV complexes remain unclear. Herein, we demonstrate that inhibition of stearoyl-CoA desaturase 1 (SCD-1) halts the biosynthesis of unsaturated fatty acids, such as oleic acid, and negatively modulates HCV replication. Unsaturated fatty acids play key roles in membrane curvature and fluidity. Mechanistically, we demonstrate that SCD-1 inhibition disrupts the integrity of membranous HCV replication complexes and renders HCV RNA susceptible to nuclease-mediated degradation. Our work establishes a novel function for unsaturated fatty acids in HCV replication.

[1]  Ralf Bartenschlager,et al.  A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C. , 2003, Journal of virological methods.

[2]  Thomas Lengauer,et al.  Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. , 2011, Cell host & microbe.

[3]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[4]  G. Alvisi,et al.  Hepatitis c virus and host cell lipids: An intimate connection , 2011, RNA biology.

[5]  Andrew Ridsdale,et al.  Optimally chirped multimodal CARS microscopy based on a single Ti:sapphire oscillator. , 2009, Optics express.

[6]  Rodney K. Lyn,et al.  Direct imaging of the disruption of hepatitis C virus replication complexes by inhibitors of lipid metabolism. , 2009, Virology.

[7]  S Schleich,et al.  Vaccinia virus DNA replication occurs in endoplasmic reticulum-enclosed cytoplasmic mini-nuclei. , 2001, Molecular biology of the cell.

[8]  P. Escribá,et al.  Effects of oleic acid and its congeners, elaidic and stearic acids, on the structural properties of phosphatidylethanolamine membranes Published, JLR Papers in Press, December 16, 2002. DOI 10.1194/jlr.M200356-JLR200 , 2003, Journal of Lipid Research.

[9]  J. Mackenzie Wrapping Things up about Virus RNA Replication , 2005, Traffic.

[10]  G. Meer,et al.  Membrane lipids: where they are and how they behave , 2008, Nature Reviews Molecular Cell Biology.

[11]  M. Aoki,et al.  Host sphingolipid biosynthesis as a target for hepatitis C virus therapy , 2005, Nature chemical biology.

[12]  Ricardo Macarron,et al.  Identification and Biological Characterization of Heterocyclic Inhibitors of the Hepatitis C Virus RNA-dependent RNA Polymerase* , 2002, The Journal of Biological Chemistry.

[13]  Robert G. Parton,et al.  Opinion: Lipid droplets: a unified view of a dynamic organelle , 2006, Nature Reviews Molecular Cell Biology.

[14]  R. Oballa,et al.  Biological activity and preclinical efficacy of azetidinyl pyridazines as potent systemically-distributed stearoyl-CoA desaturase inhibitors. , 2011, Bioorganic & medicinal chemistry letters.

[15]  R. Bartenschlager,et al.  The lipid droplet is an important organelle for hepatitis C virus production , 2007, Nature Cell Biology.

[16]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[17]  Soon B. Hwang,et al.  Hepatitis C Virus RNA Replication Occurs on a Detergent-Resistant Membrane That Cofractionates with Caveolin-2 , 2003, Journal of Virology.

[18]  M. Ott,et al.  Unique ties between hepatitis C virus replication and intracellular lipids , 2011, Trends in Endocrinology & Metabolism.

[19]  J. Ntambi,et al.  Biochemical and physiological function of stearoyl-CoA desaturase. , 2009, American journal of physiology. Endocrinology and metabolism.

[20]  A. D. Smith,et al.  The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. , 1984, Biochimica et biophysica acta.

[21]  L. Wodicka,et al.  Genomic analysis of the host response to hepatitis C virus infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  David A. Powell,et al.  Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia. , 2011, Journal of medicinal chemistry.

[23]  K. Chayama,et al.  Hepatitis C Virus Core Protein Modulates Fatty Acid Metabolism and Thereby Causes Lipid Accumulation in the Liver , 2005, Digestive Diseases and Sciences.

[24]  J. Falgueyret,et al.  Synthesis and biological activity of a potent and orally bioavailable SCD inhibitor (MF-438). , 2010, Bioorganic & medicinal chemistry letters.

[25]  J. Fontana,et al.  Virus factories: associations of cell organelles for viral replication and morphogenesis , 2005, Biology of the cell.

[26]  A. Nohturfft,et al.  Coordination of lipid metabolism in membrane biogenesis. , 2009, Annual review of cell and developmental biology.

[27]  K. Koike,et al.  Pathogenesis of lipid metabolism disorder in hepatitis C: polyunsaturated fatty acids counteract lipid alterations induced by the core protein. , 2011, Journal of hepatology.

[28]  P. Ahlquist,et al.  Mutation of Host Δ9 Fatty Acid Desaturase Inhibits Brome Mosaic Virus RNA Replication between Template Recognition and RNA Synthesis , 2001, Journal of Virology.

[29]  R. Oballa,et al.  SAR and optimization of thiazole analogs as potent stearoyl-CoA desaturase inhibitors. , 2010, Bioorganic & medicinal chemistry letters.

[30]  R. Oballa,et al.  Nicotinic acids: liver-targeted SCD inhibitors with preclinical anti-diabetic efficacy. , 2011, Bioorganic & medicinal chemistry letters.

[31]  A. Siddiqui,et al.  Hepatitis C Virus Induces Proteolytic Cleavage of Sterol Regulatory Element Binding Proteins and Stimulates Their Phosphorylation via Oxidative Stress , 2007, Journal of Virology.

[32]  J. Pawlotsky,et al.  Hepatitis C Virus Proteins Induce Lipogenesis and Defective Triglyceride Secretion in Transgenic Mice* , 2009, The Journal of Biological Chemistry.

[33]  R. Oballa,et al.  Discovery of potent and liver-targeted stearoyl-CoA desaturase (SCD) inhibitors in a bispyrrolidine series. , 2012, Bioorganic & medicinal chemistry letters.

[34]  P. Wydro,et al.  The influence of fatty acids on model cholesterol/phospholipid membranes. , 2007, Chemistry and physics of lipids.

[35]  D. Lavanchy,et al.  Evolving epidemiology of hepatitis C virus. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[36]  Rodney K. Lyn,et al.  Dynamics of lipid droplets induced by the hepatitis C virus core protein. , 2010, Biochemical and biophysical research communications.

[37]  John Paul Pezacki,et al.  Chemical contrast for imaging living systems: molecular vibrations drive CARS microscopy , 2011, Nature chemical biology.

[38]  John Paul Pezacki,et al.  Modulation of fatty acid synthase enzyme activity and expression during hepatitis C virus replication. , 2013, Chemistry & biology.

[39]  J. Krijnse-Locker,et al.  Modification of intracellular membrane structures for virus replication , 2008, Nature Reviews Microbiology.

[40]  R. Bartenschlager,et al.  Morphological and Biochemical Characterization of the Membranous Hepatitis C Virus Replication Compartment , 2013, Journal of Virology.

[41]  D. Hazuda,et al.  Pharmacodynamic Analysis of a Serine Protease Inhibitor, MK-4519, against Hepatitis C Virus Using a Novel In Vitro Pharmacodynamic System , 2011, Antimicrobial Agents and Chemotherapy.

[42]  D. Olsen,et al.  A time-resolved, internally quenched fluorescence assay to characterize inhibition of hepatitis C virus nonstructural protein 3-4A protease at low enzyme concentrations. , 2008, Analytical biochemistry.

[43]  J. Ntambi Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. , 1999, Journal of lipid research.

[44]  Rodney K. Lyn,et al.  Host-virus interactions during hepatitis C virus infection: a complex and dynamic molecular biosystem. , 2010, Molecular bioSystems.

[45]  J. Auwerx,et al.  Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection. , 2005, Gastroenterology.

[46]  K. Shimotohno,et al.  Hepatitis C Virus Non-structural Proteins in the Probable Membranous Compartment Function in Viral Genome Replication* , 2003, Journal of Biological Chemistry.

[47]  Lawrence C Kuo,et al.  Inhibition of Hepatitis C Virus RNA Replication by 2′-Modified Nucleoside Analogs* , 2003, The Journal of Biological Chemistry.

[48]  P. Ahlquist,et al.  Membrane-shaping host reticulon proteins play crucial roles in viral RNA replication compartment formation and function , 2010, Proceedings of the National Academy of Sciences.

[49]  Min Jung Park,et al.  HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma. , 2007, Biochemical and biophysical research communications.

[50]  Darius Moradpour,et al.  A Dynamic View of Hepatitis C Virus Replication Complexes , 2008, Journal of Virology.

[51]  Simon C Watkins,et al.  Fatty acid synthase is up‐regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production , 2008, Hepatology.

[52]  S. Emerson,et al.  Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus , 2008, Proceedings of the National Academy of Sciences.

[53]  Johannes P. Schlöder,et al.  Replication Vesicles are Load- and Choke-Points in the Hepatitis C Virus Lifecycle , 2013, PLoS pathogens.

[54]  Rodney K. Lyn,et al.  Hepatitis C virus induced up‐regulation of microRNA‐27: A novel mechanism for hepatic steatosis , 2014, Hepatology.

[55]  Ralf Bartenschlager,et al.  Architecture and biogenesis of plus-strand RNA virus replication factories. , 2013, World journal of virology.